Introduction {#Sec1}
============

The knowledge of how genes regulate differences in skeletal muscle composition and metabolism is a subject of outstanding interest in medicine and agriculture, as the type of muscle plays a role in the development of chronic metabolic diseases (Tanner et al. [@CR42]), as well as in the organoleptic properties of the meat (Thompson [@CR43]). Muscles consist of a heterogeneous population of fibres with different molecular, structural, contractile, and metabolic properties, which contribute to a wide variety of functional capabilities. In the bovine, postnatal muscles have three major fibre types encoded by the expression of three myosin heavy chain (MyHC) genes: the slow-oxidative one or type I, and two fast ones or types IIA and IIX (Maccatrozzo et al. [@CR24]; Tanabe et al. [@CR41]). Slow muscles are mainly composed of type I fibres, oriented to continuous but modest activities mediated by an aerobic metabolism. On the other hand, fast-glycolytic muscles consist of a large proportion of type II fibres and are sporadically demanded for short periods of intense muscular activity associated with anaerobic metabolism (Brent and Tabin [@CR5]). The composition of muscle tissue in bovine is known to be influenced by both the genetic background and the development prior to birth of the individuals (Lehnert et al. [@CR22]). Muscle specialisation is the result of the coordinated expression of contractile and metabolic proteins together with the histological features that characterise the fibres. This coordination has been described in bovines (Moreno-Sánchez et al. [@CR26]) and in some other species (Acevedo and Rivero [@CR1]; Quiroz-Rothe and Rivero [@CR28]). Besides the changes in the expression of the tissue-specific myosin isoforms, skeletal myofibres have the ability to undergo adaptive metabolic changes in response to external stimulus such as nutrition (Cassar-Malek et al. [@CR8]) and exercise (Flück [@CR14]). The identification of differentially expressed (DE) genes involved in the functionality of muscles (contractile, metabolic, and structural properties) and their potential relationship to differences in muscle plasticity and meat quality are recent areas of interest (Bernard et al. [@CR4]).

Microarray technology is a useful tool for the comparative study of gene expression differences and to ascertain those genes involved in the phenotypic characteristics of muscles. In cattle, although the global gene expression differences between muscles has not yet been studied using microarrays, a comparison between *Rectus abdominis* and *Semitendinosus* was performed based on human macroarrays (Sudre et al. [@CR38], [@CR39]). In addition, different microarray approaches have been developed to study the differential gene expression between phenotypically distinct muscles in swine (Bai et al. [@CR3]) and in mice (Campbell et al. [@CR7]; Wu et al. [@CR46]). Genes encoding for structural proteins and metabolic enzymes were the main DE groups in all these experiments. Other groups of DE genes included mitochondrial genes, transcription factors, and genes involved in Ca^2+^ channels. Moreover, ligands for receptor signals and extracellular matrix related genes were DE in some of these studies, suggesting the presence of species- or muscle-specific drivers of molecular characteristics of muscle.

Once the genes of interest have been detected, the next major challenge of genomics is to elucidate the functions of these genes and to discover how they interact to perform specific biological processes (Stuart et al. [@CR37]). Gene networks are a promising tool for modelling, analysis, and visualisation, being considered a semi-quantitative graphical representation of transcriptional regulation that reveals groups of functionally related genes and their regulators, and genes with high transcriptional connectivity (Hudson et al. [@CR18]). One method for building biological networks is to establish connections between genes whose expression profiles are significantly correlated. Some authors have reported that genes participating in the same pathway are often correlated under a large number of diverse conditions (Reverter et al. [@CR33]; Segal et al. [@CR36]). In fact, different transcriptional regulatory networks have been proposed attending to both the species-specific coexpression patterns (Gardner et al. [@CR15]) and the across-species ones (Stuart et al. [@CR37]), with several features being species specific. In cattle, two gene coexpression networks for skeletal muscle (from *Longissimus dorsi* data) have been inferred from microarray gene expression data coming from different experimental conditions using a cDNA platform (Reverter et al. [@CR34]) or an oligonucleotide one (Hudson et al. [@CR18]). To date, these networks represent the most comprehensive and largest bovine muscle gene profiling data set.

In the literature, the majority of studies on beef cattle concerns *Longissimus* muscle, but how to extrapolate these results to other muscle types remains challenging. The purpose of the present study was to profile the differential gene expression between two skeletal muscle types in beef cattle, *Psoas major* (PM) and *Flexor digitorum* (FD), after slaughter. To this end, three approaches are followed, including: the interpretation of the results in the light of the above-mentioned coexpression network (cDNA platform) of the *Longissimus dorsi* muscle of cattle, the assessment of the functional relationships among the DE genes and the detection of possible changes in connectivity across the skeletal muscle system. Will the relationships that exist between genes within a single muscle and species be conserved across muscle types?

Materials and methods {#Sec2}
=====================

Animal material {#Sec3}
---------------

Ten unrelated male calves of the Avileña-Negra Ibérica beef cattle breed were used for the experiment. The animals were fattened with the same diet during a finishing period of around 200 days and slaughtered when they reached commercial requirements, at an average live weight of 500 kg and 15 months of age. Tissue samples of PM and FD were collected at slaughter, immediately frozen in liquid nitrogen, and stored at −80°C until RNA isolation. Animal Care and Use Committee approval was not obtained for this study because the samples were collected from carcasses. In a previous study, we characterised the fibre composition of PM and FD, in Avileña-Negra Ibérica male calves (Moreno-Sánchez et al. [@CR26]). These two muscles were chosen because of their physiological and meat quality differences. FD exhibited a large proportion of type I (54%) and IIA (36%) fibres and lacked type IIX, while PM was composed by a large proportion of type II (21% IIA and 35% IIX) and a noticeable percentage of type I (29%) fibres.

For validation purposes using real-time RT-PCR, PM and FD samples were obtained from another 15 unrelated male calves, slaughtered under similar conditions as the individuals used in the microarray experiment. Tissue samples of PM and FD were collected and stored as described above.

Microarray methods and data acquisition {#Sec4}
---------------------------------------

The bovine fat and muscle cDNA microarray (Lehnert et al. [@CR20]; Lehnert et al. [@CR21]), arguably the most widely used in cattle muscle gene expression studies, was used in this experiment. While previous studies using the same platform revealed it to be well suited for the expression profiling of skeletal muscle (Byrne et al. [@CR6]; Lehnert et al. [@CR21], [@CR22]; Reverter et al. [@CR32], [@CR33], [@CR35]; Tan et al. [@CR40]; Wang et al. [@CR44], [@CR45]), we further addressed the coverage of the transcriptome that could be achieved by the following approach: We downloaded the most recent version (Release 8, July 6, 2009) of the "Flat Files" from the Human Protein Reference Database (HPRD; <http://www.hprd.org>) containing features of proteins such as post-translational modifications, subcellular localisation, protein--protein interactions and tissue expression. Of the 17,618 unique genes represented in the HPRD dataset, 3,925 (22.3%) are reported to be expressed in skeletal muscle. Also, 731 of the 841 genes in our platform are included in the 17,618 HPRD genes. Of these, 231 (31.6%) are reported to be expressed in skeletal muscle. These figures result in an over-representation hypergeometric test *p* value of 6.97E−10. Although oligonucleotide microarrays are nowadays becoming the standard in human, mouse and in a growing number of species, we concluded that the muscle specificity of the microarray platform used in this study makes it suitable for the expression profiling of bovine skeletal muscle.

Twenty microarray slides were hybridised following a loop design (Kerr [@CR19]) shown in Supplementary Fig. S[1](#MO2){ref-type=""}. In each slide, cDNA coming from the two types of muscles were simultaneously hybridised muscle samples belonging alternatively to the same or to two different individuals. Dye channel, red (Cy3) or green (Cy5) was swapped between muscles from one slide to the next to account for a possible dye bias.

Total RNA was isolated from frozen muscle tissue using the Qiagen RNeasy Kit (Qiagen, Hilden, Germany). RNA purity and integrity were assessed by RNA Nano Labchips in an Agilent 2100B Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The cDNA was synthesised from 30 μg of total RNA with the CyScribe™ First-Strand cDNA Labelling Kit (Amersham Biosciences), incorporating either Cy3-dUTP or Cy5-dUTP into the cDNA. Slides were pre-hybridised in a solution containing 6× SSC, 0.5% SDS and 1% bovine serum albumin (Sigma) for 1 h, and then hybridised overnight at 42°C in a solution containing 50% formamide, 6× SSC, 0.5% SDS, 5× Denhardt's, 20 μg of poly(A) (Sigma) and salmon sperm (Invitrogen). Afterwards, the slides were washed consecutively in three washing solutions (first 0.2× SSC and 0.1% SDS, second 0.2× SSC and third 0.06× SSC) and were finally dried. All the hybridisation steps were carried out in a Lucidea™ SlidePro Automated Hybridization Station (Amersham Biosciences).

Microarray slides were scanned with the GenePix 4000B scanner (Axon Instruments, Union City, CA, USA) at a resolution of 5 μm (PMT values ranging from 550 to 700 and laser power 100%). The intensity value for the Cy3 and Cy5 channels from each spot was acquired by the Gene Pix Pro 5.0 software (Axon Instruments). Invalid spots were filtered out and not included in the further normalisation and analysis processes (Díaz et al. [@CR10]). A total of 269,712 intensity readings from both channels and corresponding to 8,538 unique clones were retained for the analysis. Separate for each channel, intensity readings (*y*) were background-corrected by subtracting the background (Bg) from the foreground (Fg) intensities and log~2~-transformed to approximate a normal distribution as follows: $$\documentclass[12pt]{minimal}
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Data normalisation and analysis, and clone annotation {#Sec5}
-----------------------------------------------------

Global normalisation and analysis were jointly performed using a Bayesian approach, detailed in a previous study (Díaz et al. [@CR10]). Intensity records were analysed using the model that proved to have the best goodness of fit and the best predicting ability.

A standardised measure of the differences in gene expression for each clone (Δ~*g*~) was obtained as: $$\documentclass[12pt]{minimal}
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To determine which clones were DE, a model-based cluster analysis was applied to the Δ~*g*~ values. This analysis grouped clones according to their Δ~*g*~. The computer package BAYESMIX (Reverter et al. [@CR30]) was used. The program provided posterior probabilities of belonging to each of the clusters for each clone and statistical criteria (AIC, BIC) that allowed the determination of the number of clusters that yielded the best fit to the data. Estimates of false discovery rate (FDR) were obtained from the mixture models as in McLachlan et al. ([@CR25]), transforming the *n* finite numbers of clusters into a two-components mixture, one containing clones that are identified as potentially DE and another group formed by the potentially non-DE clones. Thus, $$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ {\text{F}}\widehat{{\text{D}}}{\text{R}} = {\sum\limits_{j = 1}^{N_{r} } {{\widehat{\tau }_{0} {\left( {wj} \right)}} \mathord{\left/ {\vphantom {{\widehat{\tau }_{0} {\left( {wj} \right)}} {N_{r} }}} \right. \kern-\nulldelimiterspace} {N_{r} }} } $$\end{document}$$where $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ {\hat{\tau }_0}\left( {{w_j}} \right) $$\end{document}$ was the posterior probability that the *j*th gene from the subgroup of DE clones (*N*~*r*~) was not DE. This has been termed as local false discovery rate (local FDR) (Efron and Tibshirani [@CR13]) and might be seen as an empirical Bayes version of the Benjamini and Hochberg methodology (Efron [@CR12]). The set of DE clones was finally obtained by establishing a desired FDR for the experiment.

Each DE clone was annotated after BLAST searches (Altschul et al. [@CR2]) against different available databases. Gene ontology annotation and enrichment analysis of functional annotation were performed using the David database (Huang et al. [@CR17]) and GOrilla (Eden et al. [@CR11]).

Validation by TaqMan real-time RT-PCR {#Sec6}
-------------------------------------

Real-time RT-PCR, with TaqMan MGB probes, was performed on 11 genes, AK1, ATF4, CA3, CREG1, CRYAB, CSRP3, GPD1, LDHB, MYH1, PDLIM7 and PFKM (see gene names in Table [1](#Tab1){ref-type="table"}). Genes were chosen according to two different criteria, such as to be located in the region corresponding to FDR values between 5% and 10%, or to have a biological relevance for further studies. ACTA1 (Actin alpha1) was used as the internal reference gene as it showed negligible expression differences along the microarray experiment. The sequences of primers and probes, which were designed with the Primer Express software (Applied Biosystems, Foster City, CA, USA), are listed in the Supplementary Table S[1](#MOESM1){ref-type=""}. *In silico* specificity of the amplicons was screened by BLAST searches. Table 1Genes up-regulated in PM and FD according to their GO categories. Total number of genes up-regulated in each muscle is shown in brackets. Percentages on the left and right of each GO group are related to the number of genes up-regulated in PM and FD, respectivelyGenes up-regulated in PM (49)Genes up-regulated in FD (31)39%---*Metabolic*---13%*AK1*---Adenylate kinase 1*CA3*---Carbonic anhydrase III, muscle specific*ALDOA*---Aldolase A, fructose-biphosphate*FABP3*---Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)*ATP2A1*---ATPase, Ca++ transporting, cardiac muscle, fast twitch 1*LDHB*---Lactate dehydrogenase B*ATP6*---ATP synthase F0 subunit 6*SERINC2*---Serine incorporator 2*CKM*---Creatine kinase, muscle*CKMT2*---Creatine kinase, mitochondrial 2 (sarcomeric)*COX3*---Cytochrome *c* oxidase subunit III*CYTB*---Cytochrome *bENO3*---Enolase 3 (beta, muscle)*FBP2*---Fructose-1,6-bisphosphatase 2*GAPDH*---Glyceraldehyde-3-phosphate dehydrogenase*GPD1*---Glycerol-3-phosphate dehydrogenase 1 (soluble)*GPI*---Glucose phosphate isomerase*LDHA*---Lactate dehydrogenase A*PFKM*---Phosphofructokinase, muscle*PGAM2*---Phosphoglycerate mutase 2 (muscle)*PGM1*---Phosphoglucomutase 1*PKM2*---Pyruvate kinase, muscle*PYGM*---Phosphorylase, glycogen, muscle31%---*Muscle contraction and constituents*---26%*ACTN3*---Actinin, alpha 3*ACTB*---Actin, beta*CALM1*---Calmodulin 1*KBTBD10*---Kelch repeat and BTB (POZ) domain containing 10*CASQ1*---Calsequestrin 1*MRCL3*---Myosin regulatory light chain MRCL3*LOC520988*---Similar to myosin-binding protein C, fast-type (Fast MyBP-C)*MSN*---Moesin*MYH1*---Myosin, heavy chain 1, skeletal muscle, adult*MYL2*---Myosin, light chain 2, regulatory, cardiac, slow*MYL1*---Myosin, light chain 1, alkali; skeletal, fast*MYL6*---Myosin, light chain 6, alkali, smooth muscle and non-muscle*MYL3*---Myosin, light chain 3, alkali; ventricular, skeletal, slow*PPP1R14A*---Protein phosphatase 1, regulatory (inhibitor) subunit 14A*MYLPF*---Fast skeletal myosin light chain 2*TNNT1*---Troponin T type 1 (skeletal, slow)*MYOM2*---Myomesin (M-protein) 2, 165kDa*MYOZ1*---Myozenin 1*TNNC2*---Troponin C type 2 (fast)*TNNI2*---Troponin I type 2 (skeletal, fast)*TNNT3*---Troponin T type 3 (skeletal, fast)*TPM1*---Tropomyosin 1 (alpha)*TTN*---Titin24%---*Transcription, RNA processing, protein synthesis and modification*---26%*ARIH2*---Ariadne homolog 2 (Drosophila)*CLU*---Clusterin*ASB16*---Ankyrin repeat and SOCS box-containing 16*CREG1*---Cellular repressor of E1A-stimulated genes 1*ATF4*---Activating transcription factor 4 (tax-responsive enhancer element B67)*CRYAB*---Crystallin, alpha B*CTDSP2*---CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2*EEF1A1*---Eukaryotic translation elongation factor 1 alpha 1*GMPR*---Guanosine monophosphate reductase*EIF2AK1*---Eukaryotic translation initiation factor 2-alpha kinase 1*ITGB1BP3*---Integrin beta 1 binding protein 3*LOC512251*---Similar to heat shock 27kDa protein family, member 7*LOC493779*---18S ribosomal RNA*RPLP0*---Ribosomal protein, large, P0*MLF1*---Myeloid leukaemia factor 1*UBA52*---Ubiquitin A-52 residue ribosomal protein fusion product 1*PPP1R8*---Protein phosphatase 1, regulatory (inhibitor) subunit 8*PTMA*---Prothymosin, alpha (gene sequence 28)*RPS7*---Ribosomal protein S7*rRNA*---Ribosomal RNA6%---*Muscle development and regeneration*---16%*CWF19L1*---CWF19-like 1, cell cycle control*CSRP3*---Cysteine and glycine-rich protein 3*PEBP4*---Phosphatidylethanolamine-binding protein 4*FHL1*---Four and a half LIM domains 1 (FHL1), transcript variant 3*PDLIM7*---PDZ and LIM domain 7 (enigma)*INO80B*---INO80 complex subunit B*MUSTN1*---Muskuloskeletal, embryonic nuclear protein 1*TPT1*---Tumour protein, translationally controlled 10.0%---*Extracellular matrix*---19%*COL1A1*---Collagen type I, alpha 1*COL1A2*---Collagen type I, alpha 2*COL3A1*---Collagen type III, alpha 1*DCN*---Decorin*SPARC*---Secreted protein, acidic, cysteine-rich (osteonectin)*VIM*---Vimentin

Real Total ARN Spin Plus kit (Durviz, Valencia, Spain) was used for DNA-free total RNA isolation. RNA quantification and quality control were performed using NanoDrop ND-1000 UV/Vis (Nanodrop Technologies). DNA contamination absence was determined by control PCR in which the reverse transcription step was suppressed. The reactions were set by TaqMan One-Step RT-PCR Master Mix kit (Applied Biosystems). RT-PCR amplification reactions (25 µl) contained 40 ng total RNA, 1× Master Mix without UNG, 1× MultiScribe™ and RNase Inhibitor Mix, 100 nM each of the forward and reverse primers for the internal reference gene, 100 nM each of the forward and reverse primers for the tested gene, and 100 nM each of the TaqMan probes. Reactions were run on an ABI PRISM 7500 Fast Sequence Detector (Applied Biosystems) following the manufacturer's cycling parameters. Each reaction was repeated three times. The corresponding mRNA levels were measured and analysed by the 7500 System Software (Applied Biosystems). Statistical analysis to assess differences between muscles was performed on the ∆Ct. Both parametric (paired *t* tests) and non-parametric (Wilcoxon rank-sum test) tests were used to check the consistency of the results. The relative quantification between muscles was done using normalised $\documentclass[12pt]{minimal}
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Integration on the gene coexpression network {#Sec7}
--------------------------------------------

To infer coexpression patterns for the DE genes, the list of DE genes were input in the database of the bovine gene coexpression network (Reverter et al. [@CR34]). This gene coexpression network was constructed by integrating the data from 147 microarray hybridisations corresponding to nine seemingly independent experiments and spanning a total of 47 experimental conditions or treatments. Following normalisation via a multivariate mixed ANOVA model, significant gene-to-gene associations were identified using partial correlation coefficients coupled with an information theory approach. The numerical algorithm was later formalised (Reverter and Chan [@CR29]). A sub-matrix of correlations between pairs of genes to depict coexpression patterns was obtained for the DE genes detected in this experiment that were present in the network.

Results {#Sec8}
=======

Differentially expressed genes and validation by Taqman real-time RT-PCR {#Sec9}
------------------------------------------------------------------------

Model-based cluster analysis revealed that the model considering three clusters was the one that best fit the data. The central cluster contained those clones with the largest probability of being non-DE. Two FDR values, 5% and 10%, were imposed as cut-off points. For the FDR of 5%, 72 genes were identified as DE. After relaxing the FDR to 10%, 84 genes were deemed to be DE.

In order to validate the microarray results, differential expression of 11 DE genes was further analysed by TaqMan real-time RT- PCR. These genes were mostly a sample of the DE genes detected between the 5% FDR and the 10% FDR. Results were consistent both with the microarray experiment and between parametric and non-parametric tests, indicating that all genes showed significant differential expression between muscles. The *p* values were smaller or equal than 0.001 for all genes except for two, GREG1 and GPD1, which had *p* values smaller than 0.05 and 0.01, respectively. Supplementary Table S[1](#MOESM1){ref-type=""} shows the log~2~ of the average *n*-fold differences in the muscle in which the corresponding gene appeared up-regulated (PM: ATF4, GPD1, MYH1, PDLIM7 and PFKM genes; FD: CA3, CREG1, CRYAB, CSRP3 and LDHB genes). AK1 did not show any level of expression in the FD muscle. Provided that all genes used in the validation experiment showed differential expression, the 84 genes found as DE considering a 10% FDR were further investigated.

Gene annotation and ontology {#Sec10}
----------------------------

Putative gene functions could be assigned to 80 out of the 84 genes, 49 up-regulated in PM and 31 in FD. The remaining four genes, which are up-regulated in PM, matched to bovine sequences of unknown function. Table [1](#Tab1){ref-type="table"} provides a summary of the gene ontology (GO) annotation of the 80 DE genes. The gene symbol and name, the Gene ID, the number of DE array elements per gene and the normalised fold expression changes are shown in Supplementary Tables S[2](#MOESM2){ref-type=""} and S[3](#MOESM3){ref-type=""} for PM and FD, respectively. Most of the genes were represented by more than one clone on the microarray, ranging from 1 to 19, due to the redundancy of the non-normalised cDNA libraries used to build the array. The normalised fold changes ranged from 1.50 to 15.82, and for those genes represented by more than one clone, the minimum and maximum values are given.

The same GO functional groups appeared represented in both muscles, except for the extracellular matrix related group that was only represented in the FD muscle samples. The proportion of genes in each group varied between muscles. Thus, metabolic genes were three times more represented in PM (39%) than in FD (13%). The metabolic genes detected in PM were mainly involved in glucose and glycogen metabolic processes. On the other hand, genes related to muscle development and regeneration were three times more represented in FD (16%) than in PM (6%). The DE genes coding for contractile and constituent proteins of muscle, as well as those related to the different mechanisms involved in gene expression and protein modification, presented similar percentages in both muscles (24% and 31%).

Integration on the gene coexpression network {#Sec11}
--------------------------------------------

The list of 84 DE genes was input in the database of the bovine gene coexpression network (Reverter et al. [@CR33]) to infer coexpression patterns. As previously mentioned, this network has been constructed based on 47 experimental conditions and using the same microarray platform as the one used in the present study. The use of the same platform will provide a higher level of consistency in interpretation than would be achieved if different platforms were used.

Figure [1](#Fig1){ref-type="fig"} shows the heat map of the coexpression correlation matrix for 61 out of the 84 DE genes. Thirty nine of them were up-regulated in PM (upper left corner of the correlation matrix) and 22 in FD (lower right corner). The remaining 23 DE genes did not appear in the coexpression network, as they were not differentially expressed in the experiments used to build it. Different groups of coexpression could be established according to the strong and positive correlation values (reddish colours) among genes in each muscle. The largest group was formed by 28 genes up-regulated in PM listed from *ATP2A1* to *MYOM2* in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Correlation matrix among the differentially expressed genes. The 39 genes located in the *upper left corner* of the correlation matrix corresponded to genes up-regulated in *Psoas major*. The 22 genes located in the *lower right corner* corresponded to genes up-regulated in *Flexor digitorum*. Gene ontology annotations are indicated within each muscle. Genes belonging to the same GO within each muscle are grouped inside a *green square*

Discussion {#Sec12}
==========

As in similar studies (Bai et al. [@CR3]; Bernard et al. [@CR4]; Campbell et al. [@CR7]; Sudre et al. [@CR39]), the microarray profiling of PM versus FD detected changes in gene expression that were mainly related to muscle contraction/structural constituents and to metabolic processes (54% of DE genes). Muscle contraction and constituents genes shown in Table [1](#Tab1){ref-type="table"} constituted one of the major groups of DE genes. MYH1, the gene coding for the IIX fibre type, was up-regulated in PM, the only muscle exhibiting the IIX fibres in this study. In addition to the myosin heavy chains, a profile for myosin light chains was observed. MYL1, MYL3 and MYLPF were up-regulated in PM, while MYL2 and MYL6 were up-regulated in FD. MYL1, MYL3 and MYLPF appeared in a gene coexpression group in Fig. [1](#Fig1){ref-type="fig"} with MYH1, whereas MYL2 showed an independent pattern, which was consistent with its up-regulation in FD muscle. Thirteen genes coding for enzymes involved in the metabolism of sugars, Metabolic genes in Table [1](#Tab1){ref-type="table"}, were up-regulated in PM, providing this muscle with the metabolic transcriptomic profile of a muscle with a predominance of fast fibre types. A group of six genes, from CKM to PYGM in Fig. [1](#Fig1){ref-type="fig"}, showed a strong positive coexpression pattern to genes from ACTN3 to MYH1, reflecting the physiological coordination required to store and sequester glycogen and phosphocreatine, the preferred substrates of the faster fibre types (Garrett and Kirkendall [@CR16]). While glycolytic activity was significantly higher in PM than in FD, no differences were observed between the oxidative activities of PM and FD in previous experiments (Moreno-Sánchez et al. [@CR26]), and the gene expression pattern agreed with those results. Besides the genes coding for glycolytic enzymes, the mitochondrial genes, ATP6, COX3 and CYTB, which have key roles in the oxidative phosphorylation pathway, were up-regulated in PM. Although these mitochondrial genes were not present in Fig. [1](#Fig1){ref-type="fig"}, CKMT2, a component of the mitochondria, was clustered in the coexpression group of the metabolic and structural genes and highly co-expressed with MYH1, reflecting the adaptations required for the oxidative characteristics of fast fibre types in PM.

Muscle specialisation is the result of the coordinated expression of contractile and metabolic proteins together with histological features that characterise the fibres (Acevedo and Rivero [@CR1]; Quiroz-Rothe and Rivero [@CR28]). The cellular presence of the various MyHC isoforms has been found to be coordinated with the metabolism (oxidative or glycolytic) and the morphological features in FD and PM (Moreno-Sánchez et al. [@CR26]). As previously mentioned, expression of fast-glycolytic fibre related genes was positively correlated with expression of genes for glycolytic enzymes in PM (Fig. [1](#Fig1){ref-type="fig"}), which is consistent with the simultaneous up-regulation of metabolic and structural genes in PM. This indicates that the coordination established at the biochemical level also exists at the transcriptional level. However, the magnitude of the correlations between fibre attributes at both the biochemical (Moreno-Sánchez et al. [@CR26]) and the transcriptomic levels (Fig. [1](#Fig1){ref-type="fig"}) suggested that properties of muscles may not be fully explained by their fibre type composition. Nevertheless, coordination of oxidative and contractile properties of FD could not be established because these two muscles did not exhibit oxidative differences and the difference in type I fibres between FD and PM (25%) was not supported at the transcriptional level. However, the gene encoding for the type I fibres (MYH7) consistently showed higher expression in FD than in PM (data not shown). Understanding these relationships will assist to ascertain the ability of muscles to react as a result of environmental factors such as exercise demand, changes in nutrition and disease challenge.

Organoleptic properties in meat may result from a combination of different biological processes (Bernard et al. [@CR4]), and the relationship between meat quality and muscle attributes is not fully understood. The differential expression of some of the genes in Table [1](#Tab1){ref-type="table"} has been associated with different meat quality traits (Reverter et al. [@CR35]). Specifically, the up-regulation of CRYAB and CSRP3 has been associated with low sensory scores of tenderness, flavour and juiciness (Bernard et al. [@CR4]), which corresponded to the meat properties of FD in this comparison, in which CRYAB and CSRP3 were up-regulated. In addition, different heat shock proteins, including Hsp27 (LOC512251 in Table [1](#Tab1){ref-type="table"}), have been described as down-regulated in distinct sensory traits (Bernard et al. [@CR4]), favouring cytoskeleton actin disorganisation and degradation. Its up-regulation in FD might suggest that actin was mediating in the toughness of this muscle. Down-regulation of CRYAB, MUSTN1 and CSRP3 could also improve meat tenderness (Reverter et al. [@CR34]), agreeing with the fact that PM is more tender than FD (Díaz et al. [@CR9]). Among other meat quality properties, differences in intramuscular fat content (IMF) have been described between FD and PM (Díaz et al. [@CR9]), with PM showing higher IMF. However, two fat-related genes (FABP3 and CLU) appeared up-regulated in FD. In addition, up-regulation of CRYAB and FHL1 have been found to be associated with exercise endurance in mice (Wu et al. [@CR46]); thus, their up-regulation in FD confirmed the endurance capability of this muscle. Although FD has an endurance-oxidative muscle profile, it requires further investigation as this profile was not supported by the DE of mitochondrial or oxidative metabolism related genes.

Changes in connectivity between genes across GO groups were found. Since the platform used in this experiment is the same one used to develop the network, it allowed a robust comparison with the large integrated analysis previously undertaken across a range of experimental conditions (Reverter et al. [@CR33]) and provided better consistency in interpretation than would we achieved if different platforms were used. Thus, four members of the troponin complex were DE, three fast forms (TNNC2, TNNI2 and TNNT3) in the PM and a slow form (TNNT1) in the FD (Table [1](#Tab1){ref-type="table"}). Although all of them were involved in the striated muscle contraction and the transport of Ca^2+^, their coexpression patterns in Fig. [1](#Fig1){ref-type="fig"} were different from the initially anticipated. The expression of TNNT1 was positively correlated to the rest of the troponins and genes up-regulated in PM, when it was expected to be independent or negatively correlated to them as they were up-regulated in different muscles. It represented a change in connectivity of these genes in the present comparison. Correlation patterns between troponins need further investigation as they differ in our experiment from the multiple conditions represented in the gene coexpression network (Fig. [1](#Fig1){ref-type="fig"}). In addition to these changes in connectivity (Reverter et al. [@CR34]) found between muscles, some others were also observed in the coexpression matrix, when the correlations among up-regulated genes within muscle are 0 or negative, as shown for FD in Fig. [1](#Fig1){ref-type="fig"}. Under the experimental conditions used to build the bovine network (Reverter et al. [@CR33]), the group genes from LDHB to MRCL3 in Fig. [1](#Fig1){ref-type="fig"} were negatively correlated to the genes from KBTBD10 to UBA52. However, all of them were up-regulated in FD and, therefore, expected to show a positive correlation. It is noticeable that some of the genes up-regulated in FD had a different coexpression pattern under conditions such as nutritional restriction or different quality diets, with extracellular matrix (ECM) genes being down-regulated while CSRP3 and EEF1A1 were up-regulated (Reverter et al. [@CR31]; Byrne et al. [@CR6]; Lehnert et al. [@CR21]). These genes appeared in many comparisons, and the changes in connectivity shown in our experiment illustrated how gene interactions can behave differentially under distinct experimental conditions.

Among the Transcription, RNA processing, protein synthesis and modification genes in Table [1](#Tab1){ref-type="table"}, two transcription factors (TF), ATF4 and CREG1, were found up-regulated in PM and FD, respectively. Although recent studies in human did not find any association between TF mRNA levels and muscle type (Plomgaard et al. [@CR27]), ATF4 correlated positively with all structural and metabolic genes up-regulated in PM (Fig. [1](#Fig1){ref-type="fig"}) and negatively or not correlated to ECM-related genes up-regulated in FD. Given that almost 20% of genes up-regulated in FD were related to ECM (Table [1](#Tab1){ref-type="table"}), it is worth highlighting that the expression of these genes has been described to show a decreasing trend across muscle development (Hudson et al. [@CR18]). Our results suggest a differential evolution of PM and FD. Differences in transcriptional regulation underpin much biological variation. TF would be the key in silencing genes related to ECM in PM and inducing them in FD muscle at adult ages. This point illustrated how the different specialisation and evolution of muscles can alter the established relationships between genes and open new hypothesis to a deeper investigation of the role of TF in muscle specialisation. Decoding causal transcriptional regulation remains challenging in muscle, as only a small number of well characterised TF is proposed to regulate development (Hudson et al. [@CR18]). An additional change in connectivity affected a gene involved in translation in PM. RPS7, up-regulated in PM, showed a strong and negative correlation (blue colour) to structural and metabolic genes up-regulated in PM (Fig. [1](#Fig1){ref-type="fig"}). There were also some genes involved in translation up-regulated in FD (RPLP0 and EEF1A1), which, in agreement to our pattern of expression, showed a strong negative correlation to structural and metabolic genes up-regulated in PM. These results indicated that the ribosomal synthetic machinery was active in both muscles and that this up-regulation seemed to be coupled with the down-regulation of genes involved in fast-glycolytic features in the gene network conditions.

In conclusion, the present results confirm the existence of a muscle-dependent transcription pattern and the fact that the correlation among genes (which are not immutable) depends on the muscle type. Changes in connectivity were found in the different GO groups. These results also suggest the necessity of different muscle type data integration in order to perform a comprehensive network able to describe the transcriptional landscape of bovine skeletal muscle.
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